Big Pharma Doubles Down on China

The booth of pharmaceutical company Eli Lilly in a section for 'Public Health and Epidemic Prevention' at the 3rd China International Import Expo in Shanghai, November 6, 2020. *Credit: Zhang Yuwei/Xinhua via Getty Images*

While many foreign businesses are scaling back in China, U.S. pharmaceutical giant Eli Lilly is going against the grain with a string of new investments. Eli Lilly officials pose during an expansion ceremony held at the company's site in Suzhou, October 11, 2024. Credit: Eli Lilly The Indianapolis-based company is plowing $212 million to expand its plant in Suzhou, it announced on WeChat last month. The expansion, which will bring its total investment since 1996 in the southeastern city t

Subscribe or login to read the rest.

Subscribers get full access to:

Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from Andrew Peaple.
A daily roundup of China finance, business and economics headlines.

We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.

Face-Off: U.S. vs. China

A podcast about the turbulent relationship between the world's two superpowers, the two men who run them, and the vital issues that affect us all.

US Ambassador Nicholas Burns recently served in Beijing for three years. In this episode of Face-Off: US vs. China, host Jane Perlez talks to Burns about how he got Americans out of Chinese jails, how security operatives stopped American cultural groups from performing, and how China agreed to limits on AI in nuclear weapons.

The Wire China

Big Pharma Doubles Down on China

Foreign pharmaceutical firms are eyeing the world’s second largest market for profit opportunities as well as innovative assets.

The China Hawks’ China Hawk

London Deal Offers Little Solace for Chinese Students
By Noah Berman and Dean Minello

Chenggang Xu on Why It’s Right To Call China Totalitarian
By Evan Peng

LISTEN NOW

Face-Off: U.S. vs. China
A podcast about the turbulent relationship between the world's two superpowers, the two men who run them, and the vital issues that affect us all.

The Wire China Archives

London Deal Offers Little Solace for Chinese Students By Noah Berman and Dean Minello

Chenggang Xu on Why It’s Right To Call China Totalitarian By Evan Peng

Face-Off: U.S. vs. ChinaA podcast about the turbulent relationship between the world's two superpowers, the two men who run them, and the vital issues that affect us all.

The Wire China Archives

London Deal Offers Little Solace for Chinese Students
By Noah Berman and Dean Minello

Chenggang Xu on Why It’s Right To Call China Totalitarian
By Evan Peng

Face-Off: U.S. vs. China
A podcast about the turbulent relationship between the world's two superpowers, the two men who run them, and the vital issues that affect us all.